Prevalence and Correlates of Echocardiographic Left Atrial Enlargement in Hypertensive Outpatients in Clinical Practice

Prevalence of left atrial enlargement (LAE) in hypertension has been mostly assessed in population-based samples and selected hypertensive groups. A few data are available in clinical practice. We examined LAE prevalence and severity in a cohort of hypertensive patients referred by general practitioners to a routine echocardiographic examination. A total of 2170 hypertensive individuals (mean age 62 years, 53% men) referred by practitioners to 17 outpatient echocardiographic laboratories across Italy for detection of hypertensive cardiac disease were included in the study. LAE was defined as: A) absolute LA diameter >4.0 cm in men and >3.8 cm in women; B) LA diameter normalized to body surface area (BSA) >2.3 cm/m2 in both sexes. Left atrial enlargement was graded as mild, moderate, and severe according to Lang’s report. Patients with LAE were 38% by criterion A, and 20% by criterion B. A moderate/severe increase in LA size was present in 34% (A) and 32% (B) of patients with LAE. Severe LAE was 3.3-fold (A) and 2.6-fold (B) more frequent in women than in men. Left ventricular mass was the strongest correlate of absolute LA diameter as well as of normalized LA diameter, after age. Left atrial enlargement defined either by absolute or normalized LA diameter is a frequent cardiac phenotype in hypertensive patients referred to echo-labs in clinical practice. This cardiac parameter is closely related to LV mass and its severity is highly prevalent in women.

[1]  Ahmed Methab Athab Al Missary احمد مذب عذاب المساري.  Echocardiographic Predictors of Non Rheumatic Atrial Fibrillation , 2011 .

[2]  M. Muiesan,et al.  Echocardiography in clinical practice: the burden of arterial hypertension. A multicenter Italian survey , 2010, Journal of Human Hypertension.

[3]  D. Ross,et al.  Left atrial phasic volumes are modulated by the type rather than the extent of left ventricular hypertrophy. , 2010, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  M. Gold.  Atrial Fibrillation at Baseline and During Follow-Up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) , 2010 .

[5]  B. Davis,et al.  Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial). , 2009, Journal of the American College of Cardiology.

[6]  H. Hense,et al.  The aging process of the heart: obesity is the main risk factor for left atrial enlargement during aging the MONICA/KORA (monitoring of trends and determinations in cardiovascular disease/cooperative research in the region of Augsburg) study. , 2009, Journal of the American College of Cardiology.

[7]  Jeffrey C. Hill,et al.  Left Atrial Volume and Geometry in Healthy Aging: The Cardiovascular Health Study , 2009, Circulation. Cardiovascular imaging.

[8]  C. Tsioufis,et al.  Left ventricular mass but not geometry determines left atrial size in the early stages of hypertension , 2009, Journal of Human Hypertension.

[9]  H. Uno,et al.  Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. , 2008, European heart journal.

[10]  A. Boyd,et al.  Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. , 2008, American heart journal.

[11]  Euan A Ashley,et al.  Does Size Matter?: Clinical Applications of Scaling Cardiac Size and Function for Body Size , 2008, Circulation.

[12]  Anushka Patel,et al.  Body mass index is an independent determinant of left atrial size. , 2008, Heart, lung & circulation.

[13]  R. Devereux,et al.  Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial , 2007, Hypertension.

[14]  Sverker Jern,et al.  Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. , 2006, JAMA.

[15]  G. Cioffi,et al.  Influence of age on the relationship between left atrial performance and left ventricular systolic and diastolic function in systemic arterial hypertension. , 2006, Experimental and clinical cardiology.

[16]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  D. Singer,et al.  Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.

[18]  J. Salonen,et al.  Left atrium size and the risk of cardiovascular death in middle-aged men. , 2005, Archives of internal medicine.

[19]  F. Magrini,et al.  Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome: The Evaluation of Target Organ Damage in Hypertension study , 2005, Journal of hypertension.

[20]  G. Cioffi,et al.  Relationship between left ventricular geometry and left atrial size and function in patients with systemic hypertension , 2004, Journal of hypertension.

[21]  T. Porter,et al.  How should left atrial size be reported? Comparative assessment with use of multiple echocardiographic methods. , 2004, American heart journal.

[22]  J. Seward,et al.  Left Atrial Volume: A Powerful Predictor of Survival After Acute Myocardial Infarction , 2003, Circulation.

[23]  Richard B. Devereux,et al.  Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study , 2002, Hypertension.

[24]  R. Sacco,et al.  Left atrial size and the risk of ischemic stroke in an ethnically mixed population. , 1999, Stroke.

[25]  R B D'Agostino,et al.  Impact of atrial fibrillation on mortality, stroke, and medical costs. , 1998, Archives of internal medicine.

[26]  R B D'Agostino,et al.  Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.

[27]  S. Vaziri,et al.  Echocardiographic Predictors of Nonrheumatic Atrial Fibrillation: The Framingham Heart Study , 1994, Circulation.

[28]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[29]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[30]  T. Cottle.  The Life Study , 1973 .